Peripheral mechanisms of burn injury-associated pain

Helen Laycock, Joao Valente, Carsten Bantel, I. Nagy

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

It is estimated that burn injury affects about 1 in 3000 people annually world-wide. Burn injury induces severe pain, which is difficult to control in the great majority of cases making burn injury-associated pain a serious clinical challenge. In order to meet this clinical need, novel targets should be identified. Like pain developing in other peripheral pathologies, burn injury-associated pain is also initiated and maintained by signalling between the injured tissues and primary sensory fibres that supply those tissues. This signalling is underlain by the formation and accumulation of a mixture of agents at the site of the injury, some of which could be targets for intervention. However, at present the composition of this "burn injury tissue fluid" is incompletely established. Here, we summarise our current understanding of the composition of this burn injury tissue fluid and explore how already known agents in that tissue fluid may activate nociceptors to initiate and maintain pain associated with burn injury.

Original languageEnglish
Pages (from-to)169-178
Number of pages10
JournalEuropean Journal of Pharmacology
Volume716
Issue number1-3
DOIs
Publication statusPublished - Sep 15 2013

Fingerprint

Pain
Wounds and Injuries
Nociceptors
Pathology

Keywords

  • Burn
  • Inflammatory
  • Nociception
  • Nociceptor
  • Primary sensory neuron

ASJC Scopus subject areas

  • Pharmacology

Cite this

Peripheral mechanisms of burn injury-associated pain. / Laycock, Helen; Valente, Joao; Bantel, Carsten; Nagy, I.

In: European Journal of Pharmacology, Vol. 716, No. 1-3, 15.09.2013, p. 169-178.

Research output: Contribution to journalArticle

Laycock, Helen ; Valente, Joao ; Bantel, Carsten ; Nagy, I. / Peripheral mechanisms of burn injury-associated pain. In: European Journal of Pharmacology. 2013 ; Vol. 716, No. 1-3. pp. 169-178.
@article{be2ee5771b044a70a0865cd0799540d5,
title = "Peripheral mechanisms of burn injury-associated pain",
abstract = "It is estimated that burn injury affects about 1 in 3000 people annually world-wide. Burn injury induces severe pain, which is difficult to control in the great majority of cases making burn injury-associated pain a serious clinical challenge. In order to meet this clinical need, novel targets should be identified. Like pain developing in other peripheral pathologies, burn injury-associated pain is also initiated and maintained by signalling between the injured tissues and primary sensory fibres that supply those tissues. This signalling is underlain by the formation and accumulation of a mixture of agents at the site of the injury, some of which could be targets for intervention. However, at present the composition of this {"}burn injury tissue fluid{"} is incompletely established. Here, we summarise our current understanding of the composition of this burn injury tissue fluid and explore how already known agents in that tissue fluid may activate nociceptors to initiate and maintain pain associated with burn injury.",
keywords = "Burn, Inflammatory, Nociception, Nociceptor, Primary sensory neuron",
author = "Helen Laycock and Joao Valente and Carsten Bantel and I. Nagy",
year = "2013",
month = "9",
day = "15",
doi = "10.1016/j.ejphar.2013.01.071",
language = "English",
volume = "716",
pages = "169--178",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1-3",

}

TY - JOUR

T1 - Peripheral mechanisms of burn injury-associated pain

AU - Laycock, Helen

AU - Valente, Joao

AU - Bantel, Carsten

AU - Nagy, I.

PY - 2013/9/15

Y1 - 2013/9/15

N2 - It is estimated that burn injury affects about 1 in 3000 people annually world-wide. Burn injury induces severe pain, which is difficult to control in the great majority of cases making burn injury-associated pain a serious clinical challenge. In order to meet this clinical need, novel targets should be identified. Like pain developing in other peripheral pathologies, burn injury-associated pain is also initiated and maintained by signalling between the injured tissues and primary sensory fibres that supply those tissues. This signalling is underlain by the formation and accumulation of a mixture of agents at the site of the injury, some of which could be targets for intervention. However, at present the composition of this "burn injury tissue fluid" is incompletely established. Here, we summarise our current understanding of the composition of this burn injury tissue fluid and explore how already known agents in that tissue fluid may activate nociceptors to initiate and maintain pain associated with burn injury.

AB - It is estimated that burn injury affects about 1 in 3000 people annually world-wide. Burn injury induces severe pain, which is difficult to control in the great majority of cases making burn injury-associated pain a serious clinical challenge. In order to meet this clinical need, novel targets should be identified. Like pain developing in other peripheral pathologies, burn injury-associated pain is also initiated and maintained by signalling between the injured tissues and primary sensory fibres that supply those tissues. This signalling is underlain by the formation and accumulation of a mixture of agents at the site of the injury, some of which could be targets for intervention. However, at present the composition of this "burn injury tissue fluid" is incompletely established. Here, we summarise our current understanding of the composition of this burn injury tissue fluid and explore how already known agents in that tissue fluid may activate nociceptors to initiate and maintain pain associated with burn injury.

KW - Burn

KW - Inflammatory

KW - Nociception

KW - Nociceptor

KW - Primary sensory neuron

UR - http://www.scopus.com/inward/record.url?scp=84892609485&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892609485&partnerID=8YFLogxK

U2 - 10.1016/j.ejphar.2013.01.071

DO - 10.1016/j.ejphar.2013.01.071

M3 - Article

C2 - 23500208

AN - SCOPUS:84892609485

VL - 716

SP - 169

EP - 178

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1-3

ER -